TIGIT drugs take another hit as Merck halts Phase 3 lung cancer trial over futility – Endpoints News

Sign up for free to read a limited number of articles each month.

Choose which newsletters you want to receive in your inbox each week.

Biopharmaceuticals

ENDPOINTS NEWS Daily at 11:30am ET

EARLY EDITION Daily at 7:15am ET

PHARMA ENDPOINTS Daily at 3:30pm ET

LATEST NEWS ALERTS 2-3 times a week

FDA+ ENDPOINTS Wed at 2:00pm ET

PRODUCTION END POINTS Thu at 2:00pm ET

WEEKLY END POINTS Sat at 6am ET

POST-HOC 1-2 times a week

healthcare

HEALTH TECHNOLOGY ENDPOINTS Tuesday, Thursday at 10am ET

LATEST NEWS ALERTS 2-3 times a week